High Tide Receives $8.4 Million from First Tranche Closing of Convertible Debenture Offering

CALGARY, April 22, 2019 /CNW/ – High Tide Inc. (“High Tide” or the “Company”) (CSE:HITI) (OTCQB:HTDEF) (FRA:2LY), an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today announced that it has closed the first tranche of the sale of unsecured convertible debentures (the “Debentures”) of the Company under the non-brokered private placement (the “Offering”) previously announced on April 10, 2019, with gross proceeds of $8,360,000 to date. High Tide intends to close a second and final tranche of the Offering for aggregate gross proceeds of up to $15,000,000, which has been increased from the original amount of $10,000,000 due to strong investor demand.

FSD Pharma Receives Cannabis Sales License from Health Canada

TORONTO, April 22, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today that its wholly-owned subsidiary FV Pharma Inc. has received its Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Canada). The license went into effect on April 18, 2019.

World Class Announces Listing on Frankfurt Stock Exchange

TORONTO, April 17, 2019 (GLOBE NEWSWIRE) — World Class Extractions Inc. (CSE: PUMP) (the “Company” or “World Class”) is pleased to announce that its common shares are now listed on the Frankfurt Stock Exchange and are trading under the ticker symbol “WCF” and “WKN: A2PF9C”. The Company’s common shares continue to be listed on the Canadian Stock Exchange under the ticker symbol “PUMP”.

World Class and Quadron Enter Into Arrangement Agreement

TORONTO and VANCOUVER, British Columbia, April 16, 2019 (GLOBE NEWSWIRE) — World Class Extractions Inc. (“World Class”) (CSE: PUMP) and Quadron Cannatech Corporation (“Quadron”) (CSE: QCC) are pleased to announce that they have entered into an arrangement agreement providing for the merger of the companies (the “Agreement”).

High Tide Announces Licences and Authorizations from AGCO to Open Canna Cabana-Branded Stores in Hamilton and Sudbury

CALGARY, April 15, 2019 /CNW/ – High Tide Inc. (“High Tide” or the “Company”) (CSE:HITI) (OTCQB:HTDEF) (FRA:2LY), an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, announced that on Friday, April 12, 2019 the Alcohol and Gaming Commission of Ontario (“AGCO”) approved and issued Retail Operator Licences (the “Licences”) to High Tide’s counterparties Steven Fry and Saturninus Partners (collectively, the “Winners”) and also issued Retail Store Authorizations (the “Authorizations”) to the Winners’ respective stores Canna Cabana Hamilton (“Hamilton”) and Canna Cabana Sudbury (“Sudbury”).  The Winners are aiming to open their Canna Cabana-branded locations on or before April 20, 2019.

Drone Delivery Canada Appoints Mr. Spencer Todd to the Board of Directors

TORONTO, April 10, 2019 /CNW/ – Drone Delivery Canada Corp. (TSXV: FLT, OTC: TAKOF) (“DDC” or the “Company”) is pleased to announce the appointment of Mr. Spencer Todd to the Company’s board of directors (the “Board”).

High Hampton’s Bravo Distro Receives Approval for West Sacramento Distribution Hub

TORONTO, April 10, 2019 /CNW/ – High Hampton Holdings Corp. (CSE: HC) (FSE: 0HCN) (“High Hampton” or the “Company”), a cannabis brand and distribution company in the U.S. market, is pleased to announce that the City Council of West Sacramento unanimously approved the adoption of a Development Agreement (DA) between the City of West Sacramento and High Hampton’s wholly owned distribution arm Bravo Distro for a Conditional Use Permit (CUP). The approval permits Bravo and High Hampton to operate a wholesale cannabis distribution facility in the City’s M-1 zone.

High Tide Announces $10 Million Offering of Convertible Debentures

CALGARY, April 10, 2019 /CNW/ – High Tide Inc. (“High Tide” or the “Company”) (CSE:HITI) (OTCQB:HTDEF) (FRA:2LY), an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today announced that it has launched a non-brokered private placement for the sale of up to 10,000 convertible debentures of High Tide (the “Debentures”), at a price of $1,000 per Debenture, for gross proceeds of up to $10 million Canadian dollars (the “Offering”).  The Offering is anchored by an order from Aphria Inc. (TSX: APHA) (NYSE: APHA), a leading global cannabis company, in the amount of $4.5 million Canadian dollars.  The net proceeds of the Offering will be used by the Company to fund

Continue Reading “High Tide Announces $10 Million Offering of Convertible Debentures”

World Class Announces Strategic Investment in Alkaline Spring and Launch of Capital Markets Communications Strategy

TORONTO, April 08, 2019 (GLOBE NEWSWIRE) — World Class Extractions Inc. (CSE: PUMP) (“World Class” or the “Company”) is pleased to announce it has entered into an agreement to invest up to $3 million (the “Alkaline Financing”) by way of a private placement in Alkaline Spring Inc. (“Alkaline Spring”), a privately-held, Alberta-based natural alkaline water company. In connection with the closing of the first tranche of the Alkaline Financing today, World Class invested $2 million in consideration for 2,000 senior secured convertible debentures (“Alkaline Debentures”) of Alkaline Spring, 11,111,111 common share purchase warrants of Alkaline Spring (“Alkaline Warrants”), and acquired certain investor rights. World Class is also pleased to announce that it will be increasing its level of engagement with

Continue Reading “World Class Announces Strategic Investment in Alkaline Spring and Launch of Capital Markets Communications Strategy”

Cannara Biotech Appoints Jack Kay, Former CEO of Apotex, as New Board Director

MONTREAL, April 8, 2019 /CNW/ – Cannara Biotech (“Cannara” or the “Company”) (CSE: LOVE FRA: 8CB), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Jack Kay as a Director on Cannara’s Board, effective immediately. Mr. Kay is generally recognized as one of Canada’s leading pharmaceutical executives, having held senior positions in a number of firms, including CEO of Apotex.